APART–renal
APART–renal
Acetylcysteine to Prevent Angiography-Related Renal Tissue Injury. A trial to assess whether prophylactic N-acetylcysteine treatment prevents contrast-induced nephropathy in patients with chronic renal insufficiency (CRI) who are undergoing cardiac catheterization.Conclusion N-acetylcysteine reduces the risk of postcatheterisation nephropathy in patients with CRI.